Table 4. Peak systolic velocity (PSV) and end diastolic velocity (EDV).
| Treatment group | Baseline | 8 weeks | Difference | p-valuea |
|---|---|---|---|---|
| PSV (cm/s) | ||||
| KBMSI-2 | 10.23±5.60 | 13.64±5.99 | 3.41±5.00 | 0.0240 |
| Placebo | 12.14±4.17 | 15.11±5.28 | 2.97±3.51 | 0.0138 |
| p-valueb | 0.7974 | |||
| EDV (cm/s) | ||||
| KBMSI-2 | 3.91±2.00 | 5.42±2.62 | 1.51±2.53 | 0.0535 |
| Placebo | 5.82±3.03 | 7.03±3.35 | 1.21±2.16 | 0.0790 |
| p-valueb | 0.7458 | |||
| Resistive index | ||||
| KBMSI-2 | 0.61±0.04 | 0.60±0.09 | -0.01±0.01 | 0.8150 |
| Placebo | 0.52±0.05 | 0.53±0.05 | 0.01±0.01 | 0.7790 |
| p-valueb | 0.756 |
Values are presented as mean±standard deviation.
a:Paired t-test for comparison of difference from baseline. b:t-test for comparison of difference between groups.